Does OMAVELOXOLONE Cause Product dose omission issue? 92 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 92 reports of Product dose omission issue have been filed in association with OMAVELOXOLONE (SKYCLARYS). This represents 7.4% of all adverse event reports for OMAVELOXOLONE.
92
Reports of Product dose omission issue with OMAVELOXOLONE
7.4%
of all OMAVELOXOLONE reports
1
Deaths
21
Hospitalizations
How Dangerous Is Product dose omission issue From OMAVELOXOLONE?
Of the 92 reports, 1 (1.1%) resulted in death, 21 (22.8%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMAVELOXOLONE. However, 92 reports have been filed with the FAERS database.
What Other Side Effects Does OMAVELOXOLONE Cause?
Fatigue (118)
Nausea (101)
Hepatic enzyme increased (100)
Headache (83)
Diarrhoea (77)
Blood cholesterol increased (67)
Muscle spasms (64)
Abdominal pain upper (51)
Atrial fibrillation (48)
Urinary tract infection (47)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which OMAVELOXOLONE Alternatives Have Lower Product dose omission issue Risk?
OMAVELOXOLONE vs OMBITASVIR
OMAVELOXOLONE vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMAVELOXOLONE vs OMEGA-3-ACID ETHYL ESTERS
OMAVELOXOLONE vs OMEGA-3-CARBOXYLIC ACIDS
OMAVELOXOLONE vs OMEGA-3 FATTY ACIDS